報價延遲最少15分鐘:2025/05/31 19:53 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.07 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-20.60/-0.25
|
|
企業價值
121.36M
|
| 資產負債 |
|
每股賬面淨值
4.38
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
573.42M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 19:53 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines. |